Jung Mi Park

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Systematic Review

Helicobacter Pylori

Top Venues

Yonsei medical journal

Journal of breast cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Yura Kang, Jung Mi Park, Sang-Hak Lee
Moderate-Intensity Rosuvastatin/Ezetimibe Combination versus Quadruple-Dose Rosuvastatin Monotherapy: A Meta-Analysis and Systemic Review. Yonsei medical journal 65 (1) (2024)
Yura Kang, Jung Mi Park, Sang-Hak Lee
Moderate-Intensity Rosuvastatin/Ezetimibe Combination versus Quadruple-Dose Rosuvastatin Monotherapy: A Meta-Analysis and Systemic Review. Yonsei medical journal 65 (1) (2024)
Yura Kang, Jung Mi Park, Sang-Hak Lee
Moderate-Intensity Rosuvastatin/Ezetimibe Combination versus Quadruple-Dose Rosuvastatin Monotherapy: A Meta-Analysis and Systemic Review. Yonsei medical journal 65 (1) (2024)
Yura Kang, Jung Mi Park, Sang-Hak Lee
Moderate-Intensity Rosuvastatin/Ezetimibe Combination versus Quadruple-Dose Rosuvastatin Monotherapy: A Meta-Analysis and Systemic Review. Yonsei medical journal 65 (1) (2024)
Yura Kang, Jung Mi Park, Sang-Hak Lee
Moderate-Intensity Rosuvastatin/Ezetimibe Combination versus Quadruple-Dose Rosuvastatin Monotherapy: A Meta-Analysis and Systemic Review. Yonsei medical journal 65 (1) (2024)
Hyung Seok Park, Jeea Lee, Jee Ye Kim, Jung Mi Park, Yonghan Kwon
A Prospective Randomized Study to Compare Postoperative Drainage After Mastectomy Using Electrosurgical Bipolar Systems and Conventional Electro-Cautery. Journal of breast cancer 25 (4) (2022)
Chan Joo Lee, Bogeum Choi, Hayeon Pak, Jung Mi Park, Ji Hyun Lee, Sang-Hak Lee
Genetic Variants Associated with Adverse Events after Angiotensin-Converting Enzyme Inhibitor Use: Replication after GWAS-Based Discovery. Yonsei medical journal 63 (4) (2022)